Nilotinib
Nilotinib (brand name Tasigna) is a targeted therapy medication used in modern oncology. It is primarily utilised in cases of chronic myeloid leukaemia.
Key points
- Unlike traditional chemotherapy, it targets the specific cell-signalling pathways that drive this cancer’s growth rather than broadly disrupting cell division.
- It works by blocking the BCR-ABL protein in bone marrow, stopping the signals that let leukaemia cells multiply uncontrollably.
- Because it can affect heart rhythm and liver or kidney function, these need checking before and during treatment.
What is Nilotinib?
Nilotinib is a targeted pharmaceutical compound classified as a tyrosine kinase inhibitor. It belongs to a class of medications designed to address cellular signalling pathways involved in specific types of cancer. These treatments are distinct from traditional chemotherapy, focusing directly on the underlying drivers of the disease rather than broader cell division.
What Nilotinib is used for
Nilotinib is used to address Chronic Myeloid Leukaemia. It functions by hindering the activity of proteins that promote the uncontrolled proliferation of cancerous cells. This medication is essential in long-term treatment strategies.
How does Nilotinib work?
This medication inhibits the BCR-ABL tyrosine kinase, a protein that triggers uncontrolled cell growth in the bone marrow. By blocking this specific protein, Nilotinib prevents the signals that cause CML cells to multiply. This reduces the number of abnormal white blood cells, which allows for the recovery of healthy blood cell production.
Nilotinib brands and forms
The primary product associated with this ingredient is Tasigna. It is available as a Capsule, hard. These formulations are managed within the broader category of Oncology Support. Patients receive these to ensure consistent absorption as monitored by their clinical team.
Safety overview for Nilotinib
What to check before using this medicine
Cardiac health assessments, specifically regarding QT interval prolongation, are necessary prior to use. Liver and kidney function tests help determine if the body can process the medication effectively.
Possible reactions and tolerability
Common side effects include skin rashes, nausea, headache and fatigue. Changes in electrolyte levels or blood cell counts are monitored closely during the course of treatment.
Interactions and health factors
Concurrent medications, certain foods and various supplements can alter how the body absorbs Nilotinib. Clinical monitoring ensures that other treatments do not interfere with the efficacy of this targeted therapy.